Latest News and Press Releases
Want to stay updated on the latest news?
-
Delhi, Aug. 21, 2023 (GLOBE NEWSWIRE) -- US Bispecific Antibodies Market & Clinical Pipeline Insight 2028 Report Highlights: US Bispecific Antibodies Market Opportunity: > USD 15 Billion...
-
Delhi, Aug. 17, 2023 (GLOBE NEWSWIRE) -- Johnson & Johnson’s subsidiary Janssen made headlines again in August 2023 when the FDA approved its product talquetamab under the agency’s accelerated...
-
Delhi, Aug. 16, 2023 (GLOBE NEWSWIRE) -- US Bispecific Antibodies Market & Clinical Pipeline Insight 2028 Report Highlights: US Bispecific Antibodies Market Opportunity: > USD 15...
-
Delhi, July 26, 2023 (GLOBE NEWSWIRE) -- US Orphan Drugs Market, Drugs Sales, Price, Dosage & Clinical Trials Insight 2028 Report Highlights: US Orphan Drugs Market Opportunity: > USD 150...
-
Delhi, July 25, 2023 (GLOBE NEWSWIRE) -- US Orphan Drugs Market, Drugs Sales, Price, Dosage & Clinical Trials Insight 2028 Report Highlights: US Orphan Drugs Market Opportunity: > USD...
-
Delhi, July 24, 2023 (GLOBE NEWSWIRE) -- US Orphan Drugs Market, Drugs Sales, Price, Dosage & Clinical Trials Insight 2028 Report Highlights: US Orphan Drugs Market Opportunity: > USD 150...
-
Delhi, June 30, 2023 (GLOBE NEWSWIRE) -- Global Orphan Drugs Market & Clinical Trials Insight Report 2028 Highlights: Clinical Insight On More Than 600 Marketed Orphan DrugsClinical Insight On...
-
Delhi, June 30, 2023 (GLOBE NEWSWIRE) -- The development of multispecific antibodies, which have the potential to change the way cancer is treated, has been positively influenced by the commercial...
-
Delhi, June 30, 2023 (GLOBE NEWSWIRE) -- Global LAG-3 Inhibitor Market, Drug Sales, Price & Clinical Trials Insight 2028 Report Highlights: • Global LAG-3 Inhibitor Drug Market Opportunity...
-
Delhi, June 26, 2023 (GLOBE NEWSWIRE) -- Global Bispecific Antibody Market Opportunity & Clinical Trials Insight 2023 Report Highlights: Yearly & Quarterly Sales Insight (2018 till...